ARTICLE | Distillery Therapeutics
Endocrine / metabolic disease
December 13, 2017 1:12 AM UTC
In vitro and mouse studies suggest inhibiting SEPP1 could help treat diabetes. Screening of a mAb library via in vitro and mouse myoblast cell-based SEPP1 binding assays identified a mAb that bound th...
BCIQ Target Profiles